Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study.
Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF.
Heart Rhythm. 2022 Dec;19(12):1993-2001. doi: 10.1016/j.hrthm.2022.07.031. Epub 2022 Aug 6.
Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study.
El-Chami MF, Burke MC, Herre JM, Shah MH, Sadhu A, Niebauer MJ, Kutalek SP, Carter N, Gold MR.
Heart Rhythm. 2020 Sep;17(9):1566-1574. doi: 10.1016/j.hrthm.2020.04.036. Epub 2020 May 4.
Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety.
Wolf S, Götz G, Wernly B, Wild C.
ESC Heart Fail. 2023 Apr;10(2):808-823. doi: 10.1002/ehf2.14249. Epub 2022 Nov 29.
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR, El-Chami MF, Burke MC, Upadhyay GA, Niebauer MJ, Prutkin JM, Herre JM, Kutalek S, Dinerman JL, Knight BP, Leigh J, Lucas L, Carter N, Brisben AJ, Aasbo JD, Weiss R; S-ICD System Post Approval Study Investigators.
J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034.
Implantable cardioverter defibrillator lead performance: A systematic review and individual patient data Meta-analysis.
Giacopelli D, Azzolina D, Comoretto RI, Quartieri F, Rovaris G, Schillaci V, Gargaro A, Gregori D.
Int J Cardiol. 2023 Feb 15;373:57-63. doi: 10.1016/j.ijcard.2022.11.048. Epub 2022 Nov 29.
Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
Kutyifa V, Beck C, Brown MW, Cannom D, Daubert J, Estes M, Greenberg H, Goldenberg I, Hammes S, Huang D, Klein H, Knops R, Kosiborod M, Poole J, Schuger C, Singh JP, Solomon S, Wilber D, Zareba W, Moss AJ; MADIT S-ICD Executive Committee.
Am Heart J. 2017 Jul;189:158-166. doi: 10.1016/j.ahj.2017.04.014. Epub 2017 May 4.
Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD.
F SS, R H, A S, E J, S A, Z H, R N.
Curr Cardiol Rep. 2023 Sep;25(9):1029-1039. doi: 10.1007/s11886-023-01924-4. Epub 2023 Jul 24.
The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
Barsheshet A, Vamvouris T, Goldenberg I.
Expert Rev Med Devices. 2016 Jul;13(7):627-32. doi: 10.1080/17434440.2016.1200969. Epub 2016 Jun 27.
Adverse events following implantable cardioverter defibrillator implantation: a systematic review.
Persson R, Earley A, Garlitski AC, Balk EM, Uhlig K.
J Interv Card Electrophysiol. 2014 Aug;40(2):191-205. doi: 10.1007/s10840-014-9913-z. Epub 2014 Jun 20.
Clinical outcomes of subcutaneous implantable cardiac defibrillator implantation - Iran SICD registry.
Mehdinejadshani M, Fallah H, Kamali F, Alizadeh-Diz A, Eslami M, Golabchi A, Taherpour M, Shahabi J, Mollazadeh R, Madadi S, Azhari A, Sodagar A, Eftekharzadeh M, Oraii S, Fazelifar A, Kazemisaeed A, Ghorbanisharif A, Dalili M, Khorgami M, Heidari-Bakavoli A, Jorat M, Nikoo H, Kheirkhah J, Saravi M, Khodaparast M, Mirzaali M, Emkanjoo Z, Mirmasoumi M, Sadeghian S, Mokhtari M, Hedayati-Goudarzi M, Haghjoo M.
Pacing Clin Electrophysiol. 2023 Apr;46(4):273-278. doi: 10.1111/pace.14668. Epub 2023 Mar 2.
